Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Joan Gibert"'
Autor:
Max Hardy-Werbin, José Maria Maiques, Marcos Busto, Isabel Cirera, Alfons Aguirre, Nieves Garcia-Gisbert, Flavio Zuccarino, Santiago Carbullanca, Luis Alexander Del Carpio, Didac Ramal, Ángel Gayete, Jordi Martínez-Roldan, Albert Marquez-Colome, Beatriz Bellosillo, Joan Gibert
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The rapid spread of the severe acute respiratory syndrome coronavirus 2 led to a global overextension of healthcare. Both Chest X-rays (CXR) and blood test have been demonstrated to have predictive value on Coronavirus Disease 2019 (COVID-19
Externí odkaz:
https://doaj.org/article/3ae2a8c98443459290162cd00ba2c0fd
Autor:
Sergi Clavé, Jennifer B. Jackson, Marta Salido, Jacob Kames, Kelly M. R. Gerding, Ellen L. Verner, Eric F. Kong, Elizabeth Weingartner, Joan Gibert, Max Hardy-Werbin, Pedro Rocha, Xènia Riera, Erica Torres, James Hernandez, Gustavo Cerqueira, Donna Nichol, John Simmons, Álvaro Taus, Lara Pijuan, Beatriz Bellosillo, Edurne Arriola
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionNext-generation sequencing (NGS) is currently widely used for biomarker studies and molecular profiling to identify concurrent alterations that can lead to the better characterization of a tumor’s molecular landscape. However, further e
Externí odkaz:
https://doaj.org/article/80540fee92c8444d8cf2e823ff47914c
Autor:
Pedro Rocha, MD, Didac Ramal, MD, Enric Ripoll, MD, Laura Moliner, MD, Alex Corbera, MD, Max Hardy-Werbin, MD, PhD, Mayra Orrillo, MD, Álvaro Taus, MD, Flavio Zuccarino, MD, Joan Gibert, Júlia Perera-Bel, David Casadevall, MD, PhD, Edurne Arriola, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100115- (2021)
Introduction: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different ass
Externí odkaz:
https://doaj.org/article/aa5ac2c35017431287482d1faf250d70
Autor:
Juan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, Ramón Diez-Feijóo, Sergio Pinzón, Joan Gibert, Lierni Fernández-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sánchez-González, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. García, Lluis Colomo, Beatriz Bellosillo, Antonio Gutiérrez, Antonio Salar
Publikováno v:
Blood Advances. 7:1606-1614
Several clinical risk models have been proposed to predict the outcome of follicular lymphoma (FL). The development of next-generation sequencing technologies has allowed the integration of somatic gene mutations into clinical scores to build genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a7efb2fbd4408b7ce5027e317e42de
https://doi.org/10.1182/bloodadvances.2022007949
https://doi.org/10.1182/bloodadvances.2022007949
Autor:
Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan Jose Rodriguez-Sevilla, Concepción Fernández-Rodríguez, Sara Garcia-Avila, Patricia Velez, Joan Gibert, Lierni Fernández-Ibarrondo, Antonio Salar, Lourdes Florensa, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo
Publikováno v:
Leukemia. 36:2922-2926
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97ca855b85fc4f80234c3bd48a3071a
https://doi.org/10.1038/s41375-022-01733-8
https://doi.org/10.1038/s41375-022-01733-8
Autor:
Manuel, Pera, Joan, Gibert, Marta, Gimeno, Elisenda, Garsot, Emma, Eizaguirre, Mónica, Miró, Sandra, Castro, Coro, Miranda, Lorena, Reka, Saioa, Leturio, Marta, González-Duaigües, Clara, Codony, Yanina, Gobbini, Alexis, Luna, Sonia, Fernández-Ananín, Aingeru, Sarriugarte, Carles, Olona, Joaquín, Rodríguez-Santiago, Javier, Osorio, Luis, Grande
Publikováno v:
Annals of Surgery. 276:776-783
Objective: to develop and validate a risk prediction model of 90-day mortality (90DM) using machine learning in a large multicenter cohort of patients undergoing gastric cancer resection with curative intent. Background: the 90DM rate after gastrecto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5227b9de406761d8a226680f77d7c0e9
https://doi.org/10.1097/sla.0000000000005616
https://doi.org/10.1097/sla.0000000000005616
Autor:
Xavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Sara Garcia-Avila, Lourdes Florensa, Joan Gibert, Concepción Fernández-Rodríguez, Marta Salido, Anna Puiggros, Blanca Espinet, Luis Colomo, Beatriz Bellosillo, Ana Ferrer, Leonor Arenillas
Publikováno v:
Blood Advances. 6:3921-3931
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a5b7ecd477be138789ef9e8757de0b
https://doi.org/10.1182/bloodadvances.2022007359
https://doi.org/10.1182/bloodadvances.2022007359
Autor:
Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, Beatriz Bellosillo, Leonardo Mina, Ana Santaballa Bertran, Vanesa Quiroga, Alessandro Marco Minisini, Enrique Espinosa, Juan de la Haba, Lourdes Calvo, Begoña Bermejo, Meritxell Bellet, Joan Gibert, Laura Comerma, Manuel Ruíz-Borrego, Giuseppe Curigliano, Miguel Gil-Gil, José Manuel Pérez-García, Joan Albanell
Supplementary Table S1. Selection Criteria; Supplementary Table S2. Recruiting Sites, Principal Investigators, and Patient Numbers; Supplementary Table S3. Study Members; Supplementary Table S4. List of antibodies used for immunohistochemistry analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a7cea33a4c76d1718e21fd8603fcb7
https://doi.org/10.1158/1078-0432.22489431
https://doi.org/10.1158/1078-0432.22489431
Autor:
Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, Beatriz Bellosillo, Leonardo Mina, Ana Santaballa Bertran, Vanesa Quiroga, Alessandro Marco Minisini, Enrique Espinosa, Juan de la Haba, Lourdes Calvo, Begoña Bermejo, Meritxell Bellet, Joan Gibert, Laura Comerma, Manuel Ruíz-Borrego, Giuseppe Curigliano, Miguel Gil-Gil, José Manuel Pérez-García, Joan Albanell
Summary of all adverse events according to NCI-CTCAE version 4.0.3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72568bda800ffb38bd5bdf1659e5cc64
https://doi.org/10.1158/1078-0432.22489440
https://doi.org/10.1158/1078-0432.22489440
Autor:
Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, Beatriz Bellosillo, Leonardo Mina, Ana Santaballa Bertran, Vanesa Quiroga, Alessandro Marco Minisini, Enrique Espinosa, Juan de la Haba, Lourdes Calvo, Begoña Bermejo, Meritxell Bellet, Joan Gibert, Laura Comerma, Manuel Ruíz-Borrego, Giuseppe Curigliano, Miguel Gil-Gil, José Manuel Pérez-García, Joan Albanell
Purpose:To assess the efficacy and exploratory biomarkers of continuing palbociclib plus endocrine therapy (ET) beyond progression on prior palbociclib-based regimen in patients with hormone receptor–positive/HER2-negative (HR+/HER2−) advanced br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3e1b98440fb1afb63e5afb596035ca
https://doi.org/10.1158/1078-0432.c.6532953
https://doi.org/10.1158/1078-0432.c.6532953